With a new year comes a new set of resolutions and options in the weight loss game. Injectable GLP-1 drugs like Wegovy, Ozempic and Zepbound have helped many people across the world lose weight and ...

Now the arrival of a Wegovy pill in U.S. pharmacies feels like a line in the sand between the first and second era of ...

Novo Nordisk is the first manufacturer to market its drug Wegovy in pill form in the U.S., though Eli Lilly expects approval ...

The monthly out-of-pocket cost is less than the $349 price for monthly injections, but the savings vary by dose.

Danish drugmaker Novo Nordisk said the first-of-its kind oral pill will offer 1.5 and 4 milligram doses at $149 per month for ...

Novo Nordisk announced Monday it is making its weight loss drug Wegovy available as a pill for less than $150 a month.

Warning as appetite-suppressing injections set to be approved in Britain in pill form which will lead to them becoming ...

Cipla clarified that its supply partner Pharmathen received nine USFDA Form 483 observations during a November 2025 ...

Professors Svetlana Mojsov and Carlos Kenig, among other eminent figures, were selected to win the 48th session of the prize.

Two new groundbreaking drugs could slow the memory impairment, thinking skills and overall brain decline — and both are ...

FDA-approved semaglutide drug is the first GLP-1 pill for weight loss available in the U.S., according to drugmaker Novo Nordisk.

In early December, the 2025 updates of China’s NRDL were finalised with a total of 114 drugs, including Western drugs and ...